C12ORF65 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.2603919564167E-12 |
Normal-vs-Stage2 |
1.71235999999464E-05 |
Normal-vs-Stage3 |
2.94879998197217E-09 |
Normal-vs-Stage4 |
1.66089364483923E-12 |
Stage1-vs-Stage2 |
8.520600E-01 |
Stage1-vs-Stage3 |
9.078600E-01 |
Stage1-vs-Stage4 |
1.582050E-04 |
Stage2-vs-Stage3 |
9.309600E-01 |
Stage2-vs-Stage4 |
7.304000E-03 |
Stage3-vs-Stage4 |
4.810000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.44089209850063E-16 |
Normal-vs-AfricanAmerican |
4.90070000003229E-06 |
Normal-vs-Asian |
2.543900E-03 |
Caucasian-vs-AfricanAmerican |
7.787800E-01 |
Caucasian-vs-Asian |
8.652000E-01 |
AfricanAmerican-vs-Asian |
8.112400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62625468647093E-12 |
Normal-vs-Female |
2.18869367074603E-12 |
Male-vs-Female |
9.933600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.954000E-04 |
Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(61-80Yrs) |
9.83324532910501E-13 |
Normal-vs-Age(81-100Yrs) |
1.264120E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.096600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.466800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.495200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.159840E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.739400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.245400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.29309999996607E-06 |
Normal-vs-Grade 2 |
2.04358752142753E-12 |
Normal-vs-Grade 3 |
1.85484960724125E-12 |
Normal-vs-Grade 4 |
3.93660004593954E-09 |
Grade 1-vs-Grade 2 |
4.447000E-01 |
Grade 1-vs-Grade 3 |
4.944600E-01 |
Grade 1-vs-Grade 4 |
8.564200E-01 |
Grade 2-vs-Grade 3 |
8.045200E-01 |
Grade 2-vs-Grade 4 |
9.258400E-02 |
Grade 3-vs-Grade 4 |
1.266420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.69519953630015E-12 |
Normal-vs-ccB subtype |
4.57739957049341E-10 |
ccA subtype-vs-ccB subtype |
6.669400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.02875519003965E-12 |
Normal-vs-N1 |
1.611890E-04 |
N0-vs-N1 |
1.894000E-02 |
|
|